STOCK TITAN

PVG details Anavex 2026 proxy push in webcast

ANAVEX LIFE SCIENCES CORP.

(Neutral)
(Neutral)
Form Type
DFAN14A

Rhea-AI Filing Summary

ANAVEX LIFE SCIENCES CORP. (AVXL) is the subject of a proxy solicitation by PVG Asset Management Corporation and associated participants, who have filed a definitive proxy statement on Schedule 14A and are using a GOLD Universal Proxy Card for the Company’s 2026 annual meeting of stockholders.

On September 16, 2026, PVG held an online investor presentation and question-and-answer session via webcast at 10:00 a.m. Eastern Time; the presentation materials are attached as Exhibit 1 and a written transcript as Exhibit 2. The filing identifies PVG and six individuals as participants and includes standard cautionary language regarding forward-looking statements, urging stockholders to carefully review PVG’s definitive proxy statement and related materials available on the SEC’s website before voting.

Positive

  • None.

Negative

  • None.
Annual meeting year 2026 Year of Anavex Life Sciences Corp. annual meeting subject to PVG’s solicitation
Investor presentation date September 16, 2026 Date PVG hosted its online investor presentation and Q&A
Investor presentation start time 10:00 a.m. Eastern Time Time the webcast presentation and Q&A commenced
GOLD Universal Proxy Card regulatory
"accompanying GOLD Universal Proxy Card with the U.S. Securities"
A gold universal proxy card is a single ballot used in contested board elections that lists both the company’s nominees and challenger nominees, allowing shareholders to vote for any combination of candidates up to the number of open seats. It matters to investors because it simplifies and preserves their voting choice, reduces the likelihood that a split vote will unintentionally favor one side, and can materially influence who controls the board.
definitive proxy statement regulatory
"has filed a definitive proxy statement on Schedule 14A"
A Definitive Proxy Statement is a detailed document that a company sends to its shareholders before a big meeting, like voting on important decisions. It explains what's being voted on and gives important information so shareholders can make informed choices. It matters because it helps shareholders understand and participate in key company decisions.
Schedule 14A regulatory
"has filed a definitive proxy statement on Schedule 14A"
Schedule 14A is a document that companies file with regulators to share important information with shareholders before a big vote, like approving a merger or election of directors. It matters because it helps investors understand what’s happening so they can make informed decisions about the company’s future.
forward-looking statements regulatory
"may contain forward-looking statements within the meaning of the"
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.
Private Securities Litigation Reform Act of 1995 regulatory
"within the meaning of the Private Securities Litigation Reform Act of 1995"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What is PVG seeking from Anavex Life Sciences Corp. (AVXL) stockholders?

PVG Asset Management Corporation and other participants are soliciting proxies for Anavex’s 2026 annual meeting using a GOLD Universal Proxy Card. They have filed a definitive proxy statement on Schedule 14A outlining their solicitation and related information.

What did PVG disclose in this DFAN14A filing regarding AVXL?

PVG disclosed that it filed a definitive proxy statement and GOLD Universal Proxy Card for AVXL’s 2026 annual meeting and that it hosted an online investor presentation and Q&A on September 16, 2026, with materials and a transcript attached as exhibits.

When did PVG’s investor presentation about AVXL take place and how?

PVG’s investor presentation and question-and-answer session regarding AVXL took place on September 16, 2026, commencing at 10:00 a.m. Eastern Time. It was conducted via webcast, with accompanying presentation materials and a written transcript filed as exhibits.

Where can AVXL stockholders find PVG’s proxy materials and GOLD card?

PVG states that its definitive proxy statement, GOLD Universal Proxy Card and other relevant materials are available at no charge on the SEC’s website at https://www.sec.gov/. Stockholders are strongly encouraged to read these documents in their entirety before voting.

Does PVG’s AVXL presentation include forward-looking statements?

Yes. PVG notes that its investor presentation, transcript and related communications may contain forward-looking statements about the 2026 annual meeting, proxy solicitation, the Company, the Board, PVG nominees and shareholder value, subject to risks and uncertainties described in filings by the Company and PVG.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

(Amendment No. )

 

 

 

Filed by the Registrant ☐

 

Filed by a Party other than the Registrant ☒

 

Check the appropriate box:

 

  Preliminary Proxy Statement
     
  Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
     
  Definitive Proxy Statement
     
  Definitive Additional Materials
     
  Soliciting Material Under § 240.14a-12

 

ANAVEX LIFE SCIENCES CORP.

(Name of Registrant as Specified In Its Charter)

 

PVG ASSET MANAGEMENT CORPORATION

PATRICK S. ADAMS

JASON KOLBERT

RALF VON ZIEGESAR

RENE MORA

JOHN BORIS

CURTIS HOGUE

(Name of Persons(s) Filing Proxy Statement, if other than the Registrant)

 

Payment of Filing Fee (Check all boxes that apply):

 

  No fee required
     
  Fee paid previously with preliminary materials
     
  Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

 

 

 

 

 

 

PVG Asset Management Corporation (“PVG”), together with the other participants named herein, has filed a definitive proxy statement on Schedule 14A (the “Definitive Proxy Statement”) and accompanying GOLD Universal Proxy Card with the U.S. Securities and Exchange Commission (the “SEC”) in connection with its solicitation of proxies from stockholders of Anavex Life Sciences Corp. (Nasdaq: AVXL) (the “Company”) for the Company’s 2026 annual meeting of stockholders, including any adjournments, postponements, continuations, reschedulings or any other meeting held in lieu thereof (the “2026 Annual Meeting”).

 

On September 16, 2026, PVG hosted an online investor presentation and question-and-answer session commencing at 10:00 a.m. Eastern Time in connection with its solicitation of proxies for the 2026 Annual Meeting. The presentation was conducted via webcast and was accompanied by presentation materials. A copy of the presentation materials is attached hereto as Exhibit 1 and incorporated herein by reference. A written transcript of the presentation and question-and-answer session is attached hereto as Exhibit 2 and incorporated herein by reference.

 

Participants in the Solicitation

 

The participants in PVG’s solicitation of proxies are PVG Asset Management Corporation, Patrick S. Adams, Jason Kolbert, Ralf von Ziegesar, Rene Mora, John Boris and Curtis Hogue (collectively, the “Participants”). Information concerning the identity of the Participants and a description of their direct or indirect interests, by security holdings or otherwise, is included in PVG’s Definitive Proxy Statement and related SEC filings.

 

Forward-Looking Statements

 

The investor presentation, transcript and any related communications may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements that are not historical facts, including statements regarding PVG’s plans, objectives, beliefs, strategies and expectations relating to the 2026 Annual Meeting, the proxy solicitation, the Company, the Board of Directors, the PVG nominees, shareholder value and the potential outcome of PVG’s solicitation.

 

These statements may be identified by words such as “believes,” “expects,” “anticipates,” “plans,” “intends,” “estimates,” “may,” “will,” “would,” “could,” “should” and similar expressions, or the negative thereof. Actual results may differ materially from those projected or contemplated by these forward-looking statements due to various risks and uncertainties, including those described in applicable filings made by the Company and PVG with the SEC.

 

Stockholders are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date made. PVG does not undertake any obligation to update or revise any forward-looking statements, except as required by applicable law.

 

Important Additional Information and Where to Find It

 

PVG, together with the other Participants, has filed a definitive proxy statement on Schedule 14A and accompanying GOLD Universal Proxy Card with the SEC in connection with the solicitation of proxies from stockholders of Anavex Life Sciences Corp. relating to the 2026 Annual Meeting.

 

STOCKHOLDERS ARE STRONGLY ENCOURAGED TO READ THE DEFINITIVE PROXY STATEMENT, THE ACCOMPANYING GOLD UNIVERSAL PROXY CARD, ANY AMENDMENTS OR SUPPLEMENTS THERETO, AND ANY OTHER DOCUMENTS FILED BY PVG WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY BEFORE MAKING ANY VOTING DECISION BECAUSE THEY CONTAIN IMPORTANT INFORMATION.

 

The Definitive Proxy Statement, GOLD Universal Proxy Card and other relevant materials filed by PVG with the SEC are available at no charge at the SEC’s website at https://www.sec.gov/.

 

 

 

Keep reading